01—History
Revenue History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $14.34B
1 older move runs past ±100% (largest +209.2%); point at, tap or drag across the bars to read one.
02—Ledger
Revenue, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $14.34B | +1.0% | 10-K | |
| FY2024 | $14.20B | +8.3% | 10-K | |
| FY2023 | $13.12B | +7.8% | 10-K | |
| FY2022 | $12.17B | −24.3% | 10-K | |
| FY2021 | $16.07B | +89.1% | 10-K | |
| FY2020 | $8.50B | +29.6% | 10-K | |
| FY2019 | $6.56B | +27.4% | 10-K | |
| FY2018 | $5.15B | −12.4% | 10-K | |
| FY2017 | $5.87B | +20.8% | 10-K | |
| FY2016 | $4.86B | +18.4% | 10-K | |
| FY2015 | $4.10B | +45.5% | 10-K | |
| FY2014 | $2.82B | +34.0% | 10-K | |
| FY2013 | $2.10B | +52.7% | 10-K | |
| FY2012 | $1.38B | +209.2% | 10-K | |
| FY2011 | $445.8M | −2.9% | 10-K | |
| FY2010 | $459.1M | +21.0% | 10-K | |
| FY2009 | $379.3M | +59.1% | 10-K | |
| FY2008 | $238.5M | — | 10-K |
03—Questions
What is revenue?
Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
What is Regeneron Pharmaceuticals's current revenue?
Regeneron Pharmaceuticals (REGN) annual revenue for 2025 was $14.34B, a 0.99% increase from 2024. Regeneron Pharmaceuticals revenue for the quarter ending September 30, 2026 was $5.12B.
What was Regeneron Pharmaceuticals's revenue in 2024?
Regeneron Pharmaceuticals annual revenue for 2024 was $14.20B, a 8.27% increase from 2023.
What was Regeneron Pharmaceuticals's revenue in 2023?
Regeneron Pharmaceuticals annual revenue for 2023 was $13.12B, a 7.76% increase from 2022.
What is Regeneron Pharmaceuticals's 5-year revenue CAGR?
Regeneron Pharmaceuticals revenue grew at a compound annual growth rate (CAGR) of 11.04% from FY2020 to FY2025, going from $8.50B to $14.34B over 5 years.
- Company
- Regeneron Pharmaceuticals
- Ticker
- REGN
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations